Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 7/22: (SLTD) (LPCN) (BZUN) Higher; (XOMA) (ANGI) (CZR) Lower

July 22, 2015 12:51 PM
XOMA (Nasdaq: XOMA) 74.3% LOWER; announced the Phase 3 EYEGUARD-B study of gevokizumab in patients with Behçet's disease uveitis, run ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles